Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates

In methadone-exposed preterm neonates, early identification of those at risk of severe neonatal abstinence syndrome (NAS) and use of a methadone dosing regimen that can provide effective and safe drug exposure are two important aspects of optimal care. To this end, we reviewed 17 methadone dosing re...

Full description

Bibliographic Details
Main Authors: Samira Samiee-Zafarghandy, Tamara van Donge, Karel Allegaert, John van den Anker
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/8/3/174
_version_ 1827588360130002944
author Samira Samiee-Zafarghandy
Tamara van Donge
Karel Allegaert
John van den Anker
author_facet Samira Samiee-Zafarghandy
Tamara van Donge
Karel Allegaert
John van den Anker
author_sort Samira Samiee-Zafarghandy
collection DOAJ
description In methadone-exposed preterm neonates, early identification of those at risk of severe neonatal abstinence syndrome (NAS) and use of a methadone dosing regimen that can provide effective and safe drug exposure are two important aspects of optimal care. To this end, we reviewed 17 methadone dosing recommendations in the international guidelines and literature and explored their variability in key dosing strategies. We selected three of the reviewed dosing regimens for their pharmacokinetics (PK) characteristics and their exposure–response relationship in three gestational age groups of preterm neonates (28, 32 and 36 gestational age weeks) at risk for development of severe NAS (defined as an umbilical cord methadone concentration of ≤60 ng/mL, following fetal exposure). We applied early (12 h after birth) vs. typical (36 h after birth) initiation of treatment. We observed that use of universally recommended dosing regimens in preterm neonates can result in under- or over-exposure. Use of a PK-guided dosing regimen resulted in effective target exposures within 24 h after birth with early initiation of treatment (12 h after birth). Future prospective studies should explore the incorporation of umbilical cord methadone concentrations for early identification of preterm neonates at risk of developing severe NAS and investigate the use of a PK-guided methadone dosing regimen, so that treatment failure, prolonged length of stay and opioid over-exposure can be avoided.
first_indexed 2024-03-09T00:33:19Z
format Article
id doaj.art-41aa7611c22f416f8f79fdb4eada2b96
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-09T00:33:19Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-41aa7611c22f416f8f79fdb4eada2b962023-12-11T18:19:09ZengMDPI AGChildren2227-90672021-02-018317410.3390/children8030174Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm NeonatesSamira Samiee-Zafarghandy0Tamara van Donge1Karel Allegaert2John van den Anker3Division of Neonatology, Department of Paediatrics, McMaster University, Hamilton, ON L8S 4L8, CanadaDivision of Pediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel (UKBB), University of Basel, 4056 Basel, SwitzerlandDepartment of Clinical Pharmacy, Erasmus MC, Postbus 2040, 3000 CA Rotterdam, The NetherlandsDivision of Pediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel (UKBB), University of Basel, 4056 Basel, SwitzerlandIn methadone-exposed preterm neonates, early identification of those at risk of severe neonatal abstinence syndrome (NAS) and use of a methadone dosing regimen that can provide effective and safe drug exposure are two important aspects of optimal care. To this end, we reviewed 17 methadone dosing recommendations in the international guidelines and literature and explored their variability in key dosing strategies. We selected three of the reviewed dosing regimens for their pharmacokinetics (PK) characteristics and their exposure–response relationship in three gestational age groups of preterm neonates (28, 32 and 36 gestational age weeks) at risk for development of severe NAS (defined as an umbilical cord methadone concentration of ≤60 ng/mL, following fetal exposure). We applied early (12 h after birth) vs. typical (36 h after birth) initiation of treatment. We observed that use of universally recommended dosing regimens in preterm neonates can result in under- or over-exposure. Use of a PK-guided dosing regimen resulted in effective target exposures within 24 h after birth with early initiation of treatment (12 h after birth). Future prospective studies should explore the incorporation of umbilical cord methadone concentrations for early identification of preterm neonates at risk of developing severe NAS and investigate the use of a PK-guided methadone dosing regimen, so that treatment failure, prolonged length of stay and opioid over-exposure can be avoided.https://www.mdpi.com/2227-9067/8/3/174preterm neonatemethadoneneonatal abstinence syndromedosing
spellingShingle Samira Samiee-Zafarghandy
Tamara van Donge
Karel Allegaert
John van den Anker
Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
Children
preterm neonate
methadone
neonatal abstinence syndrome
dosing
title Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
title_full Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
title_fullStr Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
title_full_unstemmed Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
title_short Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
title_sort pharmacometric evaluation of umbilical cord blood concentration based early initiation of treatment in methadone exposed preterm neonates
topic preterm neonate
methadone
neonatal abstinence syndrome
dosing
url https://www.mdpi.com/2227-9067/8/3/174
work_keys_str_mv AT samirasamieezafarghandy pharmacometricevaluationofumbilicalcordbloodconcentrationbasedearlyinitiationoftreatmentinmethadoneexposedpretermneonates
AT tamaravandonge pharmacometricevaluationofumbilicalcordbloodconcentrationbasedearlyinitiationoftreatmentinmethadoneexposedpretermneonates
AT karelallegaert pharmacometricevaluationofumbilicalcordbloodconcentrationbasedearlyinitiationoftreatmentinmethadoneexposedpretermneonates
AT johnvandenanker pharmacometricevaluationofumbilicalcordbloodconcentrationbasedearlyinitiationoftreatmentinmethadoneexposedpretermneonates